{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:44:11Z","timestamp":1786985051570,"version":"build-2736575974"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T00:00:00Z","timestamp":1608249600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009578","name":"Mizutani Foundation for Glycoscience","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009578","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.bbrc.2020.12.051","type":"journal-article","created":{"date-parts":[[2020,12,24]],"date-time":"2020-12-24T10:16:06Z","timestamp":1608804966000},"page":"73-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Galabiosylceramide is present in human cerebrospinal fluid"],"prefix":"10.1016","volume":"536","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6394-3394","authenticated-orcid":false,"given":"Hisako","family":"Akiyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuko","family":"Ide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Yamaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuaki","family":"Mizutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2556-8167","authenticated-orcid":false,"given":"Yoshiki","family":"Niimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7712-8481","authenticated-orcid":false,"given":"Tatsuro","family":"Mutoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kamiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshio","family":"Hirabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2020.12.051_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1023\/A:1015137917508","article-title":"Glycolipid analysis of different tissues and cerebrospinal fluid in type II Gaucher disease","volume":"25","author":"Gornati","year":"2002","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.bbrc.2020.12.051_bib2","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1194\/jlr.D089797","article-title":"DMS as an orthogonal separation to LC\/ESI\/MS\/MS for quantifying isomeric cerebrosides in plasma and cerebrospinal fluid","volume":"60","author":"Xu","year":"2019","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.bbrc.2020.12.051_bib3","doi-asserted-by":"crossref","first-page":"13639","DOI":"10.1038\/s41598-018-31756-0","article-title":"Particular CSF sphingolipid patterns identify iNPH and AD patients","volume":"8","author":"Torretta","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2020.12.051_bib4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/tra.12239","article-title":"Sphingolipid metabolism and interorganellar transport: localization of sphingolipid enzymes and lipid transfer proteins","volume":"16","author":"Yamaji","year":"2015","journal-title":"Traffic"},{"key":"10.1016\/j.bbrc.2020.12.051_bib5","doi-asserted-by":"crossref","first-page":"15152","DOI":"10.1074\/jbc.M909620199","article-title":"Molecular cloning of globotriaosylceramide\/CD77 synthase, a glycosyltransferase that initiates the synthesis of globo series glycosphingolipids","volume":"275","author":"Kojima","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2020.12.051_bib6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-146-6-200703200-00007","article-title":"Narrative review: Fabry disease","volume":"146","author":"Clarke","year":"2007","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bbrc.2020.12.051_bib7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0022-2275(20)43219-5","article-title":"Biochemical and clinical analysis of accumulated glycolipids in symptomatic heterozygotes of angiokeratoma corporis diffusum (Fabry\u2019s disease) in comparison with hemizygotes","volume":"31","author":"Hozumi","year":"1990","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.bbrc.2020.12.051_bib8","doi-asserted-by":"crossref","first-page":"13382","DOI":"10.1021\/acs.analchem.7b03609","article-title":"Separation and analysis of lactosylceramide, galabiosylceramide, and globotriaosylceramide by LC-MS\/MS in urine of Fabry disease patients","volume":"89","author":"Boutin","year":"2017","journal-title":"Anal. Chem."},{"key":"10.1016\/j.bbrc.2020.12.051_bib9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nrmicro2279","article-title":"Shiga toxins--from cell biology to biomedical applications","volume":"8","author":"Johannes","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.bbrc.2020.12.051_bib10","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0021-9258(19)75706-8","article-title":"Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1","volume":"262","author":"Lindberg","year":"1987","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2020.12.051_bib11","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0022-3476(94)70001-X","article-title":"Spectrum of extrarenal involvement in postdiarrheal hemolytic-uremic syndrome","volume":"125","author":"Siegler","year":"1994","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.bbrc.2020.12.051_bib12","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1086\/341940","article-title":"Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study","volume":"186","author":"Gerber","year":"2002","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.bbrc.2020.12.051_bib13","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1086\/591911","article-title":"Shiga toxin 2 affects the central nervous system through receptor globotriaosylceramide localized to neurons","volume":"198","author":"Obata","year":"2008","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.bbrc.2020.12.051_bib14","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1194\/jlr.D076190","article-title":"Diastereomer-specific quantification of bioactive hexosylceramides from bacteria and mammals","volume":"58","author":"von Gerichten","year":"2017","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.bbrc.2020.12.051_bib15","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jchromb.2016.07.047","article-title":"Separation and analysis of mono-glucosylated lipids in brain and skin by hydrophilic interaction chromatography based on carbohydrate and lipid moiety","volume":"1031","author":"Nakajima","year":"2016","journal-title":"J.\u00a0Chromatogr. B"},{"key":"10.1016\/j.bbrc.2020.12.051_bib16","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1074\/jbc.RA119.012502","article-title":"Glucocerebrosidases catalyze a transgalactosylation reaction that yields a newly-identified brain sterol metabolite, galactosylated cholesterol","volume":"295","author":"Akiyama","year":"2020","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2020.12.051_bib17","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1227\/01.NEU.0000168185.29659.C5","article-title":"Diagnosing idiopathic normal-pressure hydrocephalus","volume":"57","author":"Relkin","year":"2005","journal-title":"Neurosurgery"},{"key":"10.1016\/j.bbrc.2020.12.051_bib18","doi-asserted-by":"crossref","first-page":"35505","DOI":"10.1074\/jbc.M110.154229","article-title":"Transmembrane BAX inhibitor motif containing (TMBIM) family proteins perturbs a trans-Golgi network enzyme, Gb3 synthase, and reduces Gb3 biosynthesis","volume":"285","author":"Yamaji","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2020.12.051_bib19","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.isci.2018.12.039","article-title":"A\u00a0CRISPR screen identifies LAPTM4A and TM9SF proteins as glycolipid-regulating factors","volume":"11","author":"Yamaji","year":"2019","journal-title":"iScience"},{"key":"10.1016\/j.bbrc.2020.12.051_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088124","article-title":"Establishment of HeLa cell mutants deficient in sphingolipid-related genes using TALENs","volume":"9","author":"Yamaji","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.bbrc.2020.12.051_bib21","doi-asserted-by":"crossref","first-page":"9490","DOI":"10.1074\/jbc.RA120.013926","article-title":"Blood group P1 antigen-bearing glycoproteins are functional but less efficient receptors of Shiga toxin than conventional glycolipid-based receptors","volume":"295","author":"Morimoto","year":"2020","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2020.12.051_bib22","doi-asserted-by":"crossref","first-page":"10265","DOI":"10.1073\/pnas.90.21.10265","article-title":"Ceramide UDPgalactosyltransferase from myelinating rat brain: purification, cloning, and expression","volume":"90","author":"Schulte","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2020.12.051_bib23","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/glia.21172","article-title":"Central nervous system dysfunction in a mouse model of FA2H deficiency","volume":"59","author":"Potter","year":"2011","journal-title":"Glia"},{"key":"10.1016\/j.bbrc.2020.12.051_bib24","doi-asserted-by":"crossref","first-page":"10230","DOI":"10.1074\/jbc.M600057200","article-title":"Targeted disruption of Gb3\/CD77 synthase gene resulted in the complete deletion of globo-series glycosphingolipids and loss of sensitivity to verotoxins","volume":"281","author":"Okuda","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2020.12.051_bib25","first-page":"29","article-title":"Localization of galactocerebroside in oligodendrocytes, myelin sheath and choroid plexus","volume":"51","author":"Uchida","year":"1981","journal-title":"Jpn. J. Exp. Med."},{"key":"10.1016\/j.bbrc.2020.12.051_bib26","article-title":"Role of sphingolipid metabolism in neurodegeneration","author":"Alaamery","year":"2020","journal-title":"J.\u00a0Neurochem."}],"updated-by":[{"DOI":"10.1016\/j.bbrc.2021.01.065","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000}}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X20322294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X20322294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T11:59:14Z","timestamp":1757764754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X20322294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":26,"alternative-id":["S0006291X20322294"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2020.12.051","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Galabiosylceramide is present in human cerebrospinal fluid","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2020.12.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}